Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa
ACS Infectious Diseases · 2023
DOI: 10.1021/acsinfecdis.2c00549 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Shiv Dhiman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Manitoba, Winnipeg R3T 2N2, Manitoba, Canada. Hauptthemen laut MEDLINE: Tobramycin, Ceftazidime. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: CIHR, Institute of Infection and Immunity, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Manitoba, Winnipeg R3T 2N2, Manitoba, Canada.
- Department of Microbiology, University of Manitoba, Winnipeg R3T 2N2, Manitoba, Canada.
- Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg R3E 0J9, Manitoba, Canada.
ORCID-Profile: Ayush Kumar, Frank Schweizer
Förderung
- CIHR
- Institute of Infection and Immunity
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Dhiman, S., Ramirez, D., Li, Y., Kumar, A., Arthur, G., & Schweizer, F. (2023). Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.2c00549
Vancouver
Dhiman S, Ramirez D, Li Y, Kumar A, Arthur G, Schweizer F. Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.2c00549
BibTeX
@article{Dhiman2023,
author = {Dhiman, Shiv and Ramirez, Danyel and Li, Yanqi and Kumar, Ayush and Arthur, Gilbert and Schweizer, Frank},
title = {Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa},
journal = {ACS Infectious Diseases},
year = {2023},
doi = {10.1021/acsinfecdis.2c00549}
}
EUVIMED